Double-blind randomized trials once a week narrowband ultraviolet B (NB-UVB) phototherapy in vitiligo
Background: Vitiligo is a skin pigmentation disorder, affecting approximately 1-2% population worldwide. Currently, there are wide varieties of treatment to achieve re-pigmentation, and phototherapy is one of the effective treatments. Narrowband ultraviolet B (NB-UVB) is administered twice a week ac...
Saved in:
Main Authors: | Retno Dwi Utami (Author), Mira Trisna Murti (Author), Muhammad Risman (Author), Arie Kusumawardhani (Author) |
---|---|
Format: | Book |
Published: |
Universitas Indonesia,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Narrowband Ultraviolet B (NB-UVB) Phototherapy in Psoriasis: A Retrospective Study
by: Faida Ufaira Prameswari, et al.
Published: (2022) -
Clinico-Epidemiological Profile of Vitiligo Patients Receiving Narrowband Ultraviolet-B (NB-UVB) Treatment
by: Anasya Putri Ramadhina, et al.
Published: (2023) -
Characteristics and decreased VASI of vitiligo patients with NB-UVB phototherapy in Yogyakarta, Indonesia
by: Nabila Kirtti Pradipta, et al.
Published: (2023) -
Narrowband UVB phototherapy in pityriasis rosea
by: Vijayeeta Jairath, et al.
Published: (2015) -
Excellent Repigmentation of Generalized Vitiligo with Oral Baricitinib Combined with NB-UVB Phototherapy
by: Li X, et al.
Published: (2023)